Hills Bank & Trust’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,273
| Closed | -$785K | – | 262 |
|
|
2021
Q2 | $785K | Sell |
4,273
-670
| -14% | -$123K | 0.12% | 114 |
|
|
2021
Q1 | $756K | Sell |
4,943
-7,332
| -60% | -$1.12M | 0.12% | 111 |
|
|
2020
Q4 | $1.92M | Buy |
12,275
+36
| +0.3% | +$5.63K | 0.34% | 69 |
|
|
2020
Q3 | $1.4M | Buy |
12,239
+1,004
| +9% | +$115K | 0.27% | 77 |
|
|
2020
Q2 | $1.26M | Sell |
11,235
-2,658
| -19% | -$298K | 0.27% | 78 |
|
|
2020
Q1 | $1.25M | Buy |
13,893
+876
| +7% | +$78.7K | 0.37% | 61 |
|
|
2019
Q4 | $1.41M | Buy |
13,017
+143
| +1% | +$15.5K | 0.33% | 67 |
|
|
2019
Q3 | $1.26M | Buy |
12,874
+3,313
| +35% | +$325K | 0.32% | 67 |
|
|
2019
Q2 | $1.25M | Buy |
9,561
+266
| +3% | +$34.9K | 0.32% | 68 |
|
|
2019
Q1 | $1.26M | Buy |
9,295
+1,120
| +14% | +$151K | 0.34% | 65 |
|
|
2018
Q4 | $796K | Buy |
8,175
+431
| +6% | +$42K | 0.25% | 79 |
|
|
2018
Q3 | $1.08M | Buy |
7,744
+456
| +6% | +$63.4K | 0.29% | 73 |
|
|
2018
Q2 | $905K | Buy |
7,288
+1,100
| +18% | +$137K | 0.26% | 71 |
|
|
2018
Q1 | $690K | Buy |
6,188
+1,025
| +20% | +$114K | 0.21% | 80 |
|
|
2017
Q4 | $617K | Buy |
5,163
+1,228
| +31% | +$147K | 0.18% | 90 |
|
|
2017
Q3 | $552K | Buy |
3,935
+637
| +19% | +$89.4K | 0.17% | 91 |
|
|
2017
Q2 | $401K | Buy |
+3,298
| New | +$401K | 0.13% | 98 |
|